Rani Therapeutics Holdings (RANI) has shared an update.
Rani Therapeutics Holdings, a company specializing in the oral delivery of biologics and drugs, has decided against pursuing equity financing for now after considering its cash reserves, market conditions, and ongoing business discussions. While they remain open to reassessing their financing strategy in the future, the company is currently not proceeding with additional equity funding.
For an in-depth examination of RANI stock, go to TipRanks’ Stock Analysis page.
